Post-Brexit MHRA Will Embrace Medtech ‘Innovation Pull’ In The UK
Global device networker role, regulatory agility and patient safety prioritized in new chapter for UK regulator
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
You may also be interested in...
The Medtech Mandate, a scheme that seeks to better match NICE guidance with adoption and use of medtech innovations in the UK, is preparing for launch in April.
How UK and EU device regulations will differ in 2021, UK approved bodies and Northern Ireland's unfettered access to the UK market were key themes at the ABHI’s annual regulatory conference.
3M’s health care company spin-off is expected to be launched in the first half of 2024 under the name Solventum.